|
|
||||||||
Ann Thorac Surg 2003;76:523-527
© 2003 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, Hebrew University, Hadassah Medical School, Jerusalem, Israel
Accepted for publication February 14, 2003.
* Address reprint requests to Dr Gerrah, Department of Cardiothoracic Surgery, Hadassah University Hospital, P.O. 12000, Jerusalem 91120, Israel
e-mail: rgerrah{at}yahoo.com
BACKGROUND: The purpose of this study was to determine whether the damaging effects of cardiopulmonary bypass, ischemia, and reperfusion would be more pronounced in patients with glucose-6-phosphate dehydrogenase deficiency undergoing cardiac surgery.
METHODS: Forty-two patients with glucose-6-phosphate dehydrogenase deficiency underwent open heart procedures using cardiopulmonary bypass. This group was matched with a control group of identical size for comparison of operative course and postoperative outcome. The perioperative variables were compared between the two groups using univariate and multivariate analysis.
RESULTS: The duration of ventilation after the operation was significantly longer in the glucose-6-phosphate dehydrogenasedeficient group (13.7 ± 7.6 hours versus 7.7 ± 2.8 hours; p < 0.0001). Minimal value of arterial oxygen tension was lower in patients with glucose-6-phosphate dehydrogenase deficiency (66 ± 12 mm Hg versus 85 ± 14 mm Hg; p < 0.0001), and more cases of hypoxia (arterial oxygen tension < 60 mm Hg) were found in this group (11 versus 1; p = 0.001). Compared with the control group, patients with glucose-6-phosphate dehydrogenase deficiency had significantly elevated hemolytic indices expressed by bilirubin levels (26 ± 10 mmol/L versus 17 ± 6.7 mmol/L; p < 0.0001) and lactic dehydrogenase levels (970 ± 496 U/L versus 505 ± 195 U/L; p < 0.0001). They also required significantly more blood transfusion perioperatively (1.9 ± 1.4 packed cell units/patient versus 0.8 ± 1.0 packed cell units/patient; p = 0.0001).
CONCLUSIONS: Patients with glucose-6-phosphate dehydrogenase deficiency who are undergoing cardiac surgery may have a more complicated course with a longer ventilation time, more hypoxia, increased hemolysis, and a need for more blood transfusion. Because this difference may be caused by subnormal free radical deactivation, strategies that minimize bypass in general and free radicals specifically may be beneficial.
This article has been cited by other articles:
![]() |
N. Dogra, G. Puri, and S. Rana Glucose-6-phosphate dehydrogenase deficiency and cardiac surgery Perfusion, November 1, 2010; 25(6): 417 - 421. [Abstract] [PDF] |
||||
![]() |
A. Anthi, R. F. Machado, M. L. Jison, A. M. Taveira-DaSilva, L. J. Rubin, L. Hunter, C. J. Hunter, W. Coles, J. Nichols, N. A. Avila, et al. Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1272 - 1279. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |